Reports

Poolbeg Pharma plc (LON:POLB) investor presentation with CEO Jeremy Skillington. Insights on company overview, key programs, progress in 2023, and market opportunities...

May 20, 2024

Healthcare Realty Trust Incorporated – Consensus ‘buy’ rating and 1.7% Upside Potential

May 17, 2024

Thermo Fisher Scientific Inc. – Consensus ‘buy’ rating and 4.2% Upside Potential

May 17, 2024

Murphy USA Inc. – Consensus ‘buy’ rating and -2.7% Downside Potential

May 17, 2024

Catalent, Inc. – Consensus ‘hold’ rating and 2.0% Upside Potential

May 17, 2024

Elevance Health, Inc. – Consensus ‘buy’ rating and 12.1% Upside Potential

May 17, 2024

EMCOR Group, Inc. – Consensus ‘buy’ rating and 5.0% Upside Potential

May 17, 2024

Chord Energy Corporation – Consensus ‘buy’ rating and 16.9% Upside Potential

May 17, 2024

Pure Storage, Inc. – Consensus ‘buy’ rating and -5.2% Downside Potential

May 17, 2024

Intuitive Surgical, Inc. – Consensus ‘buy’ rating and 6.0% Upside Potential

May 17, 2024

Confluent, Inc. – Consensus ‘buy’ rating and 11.6% Upside Potential

May 17, 2024

News and Interview Alerts

Company Presentations

Q&As

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

BrokerTalk

Funds

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

View all Funds, Market Insights and news >>

FTSE 100 News

Hiscox Ltd Have done what they set out to do in the first quarter

7 May 2019

Vodafone Group Plc Signs cable wholesale agreement with Telefónica Deutschland

7 May 2019

AstraZeneca PLC Qternmet XR approved in the US for type-2 diabetes

3 May 2019

InterContinental Hotels Group PLC 24k rooms signed, strongest Q1 pace for 12 years

3 May 2019

UK Broker Ratings

Vistry Group PLC (VTY.L) Stock Analysis: Navigating a Challenging Residential Market with Strategic Insights

9 February 2026

Standard Chartered PLC (STAN.L) Stock Analysis: Evaluating Growth Amidst Volatility and a 9.72% ROE

9 February 2026

Unilever PLC (ULVR.L) Stock Analysis: Navigating the Consumer Goods Giant’s Market Position and Analyst Ratings

9 February 2026

Weir Group PLC (WEIR.L): Analyst Ratings Highlight Strong Buy Consensus Amidst Impressive Stock Performance

9 February 2026

Reckitt Benckiser Group PLC (RKT.L) Stock Analysis: Navigating a 6.29% Upside Amid Strong ROE

9 February 2026

News

Cognizant Technology Solutions Corporation Share Price Target ‘$76.77’, now 9.6% Upside Potential

May 20, 2024

Monolithic Power Systems, Inc. Share Price Target ‘$778.40’, now 6.9% Upside Potential

May 20, 2024

Intel Corporation Share Price Target ‘$38.92’, now 21.5% Upside Potential

May 20, 2024

Super Micro Computer, Inc. Share Price Target ‘$1,057.46’, now 16.9% Upside Potential

May 20, 2024

Motorola Solutions, Inc. Share Price Target ‘$371.23’, now 1.3% Upside Potential

May 20, 2024

Teledyne Technologies Incorporated Share Price Target ‘$467.39’, now 16.2% Upside Potential

May 20, 2024

Palo Alto Networks, Inc. Share Price Target ‘$335.87’, now 6.0% Upside Potential

May 20, 2024

Lam Research Corporation Share Price Target ‘$986.49’, now 4.6% Upside Potential

May 20, 2024

Gartner, Inc. Share Price Target ‘$477.89’, now 6.7% Upside Potential

May 20, 2024

Poolbeg Pharma – Well Positioned for Success with CEO Jeremy Skillington

Poolbeg Pharma plc (LON:POLB) investor presentation with CEO Jeremy Skillington. Insights on company overview, key programs, progress in 2023, and market opportunities...